Thanks for the information. I’ve got the com
Post# of 148302
I’ve got the computer in my office at work setup and ready to stream the webcast. If I play my cards right I think I can make a 15-20 minute gap in between patients to listen to at least part of the shareholder meeting.
Like others, my hopes are tapered for what information will be released during today’s shareholder meeting but it appears that Leronlimab will be approved and brining in revenues in 2020. The question is how much more dilution is needed to get leronlimab to that point and how will the shareholders fair during that waiting period (if the BLA is delayed further).